NANTONG CITY, China, Aug. 31, 2011 (GLOBE NEWSWIRE) -- On August 30, 2011, Sinobiopharma (OTCBB:SNBP) (the “Company”) filed a Form 15 as required by Rule 15d-6, which suspends the duty of an issuer that has less than 300 holders of record of its securities as of the beginning of its fiscal year (such as the Company) to file reports with the SEC.
